Log In

Merck KGaA Forecasts Earnings, Sales Growth After In-Line Results - WSJ

Published 1 week ago1 minute read

Germany’s Merck KGaA expects earnings and sales growth this year after reporting a rise in annual earnings on temporarily reduced research and development expenses in its healthcare segment and strict cost discipline.

The life-sciences and electronics company said its earnings before interest, taxes, depreciation and amortization before one-time items–the company’s preferred profitability metric–rose 3.3% to 6.07 billion euros, equivalent to $6.55 billion, as sales rose 0.8% to 21.16 billion euros.

Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Origin:
publisher logo
WSJ
Loading...
Loading...

You may also like...